TABLE 3. Reported cases of notifiable diseases, by month*, excluding U.S. territories - - United States, 2016 column labels in same order that data fields appears in each record below: Disease Jan. Feb. Mar. Apr. May June July Aug. Sept. Oct. Nov. Dec. Total tab delimited data: Anthrax — — — — — — — — — — — — Arboviral diseases, Chikungunya virus disease 24 27 11 6 11 17 17 34 32 25 25 18 Arboviral diseases, Eastern equine encephalitis virus disease, Neuroinvasive — — — — — — 3 — 2 2 — — Arboviral diseases, Eastern equine encephalitis virus disease, Non-neuroinvasive — — — — — — — — — — — — Arboviral diseases, Jamestown Canyon virus disease, Neuroinvasive — — — — — 1 1 2 — 1 2 — Arboviral diseases, Jamestown Canyon virus disease, Non-neuroinvasive — — — — — — 2 3 2 1 — — Arboviral diseases, La Crosse virus disease, Neuroinvasive — — — — 1 1 6 7 10 4 2 — Arboviral diseases, La Crosse virus disease, Non-neuroinvasive — — — — — — 2 2 — — — — Arboviral diseases, Powassan virus disease, Neuroinvasive — — — 2 1 2 2 — 1 4 5 4 Arboviral diseases, Powassan virus disease, Non-neuroinvasive — — — — — — — — 1 — — — Arboviral diseases, St. Louis encephalitis virus disease, Neuroinvasive — — — — — 1 3 1 2 — — — Arboviral diseases, St. Louis encephalitis virus disease, Non-neuroinvasive — — — — — — 1 — — — — — Arboviral diseases, West Nile virus disease, Neuroinvasive — — — 1 7 22 151 448 383 174 64 58 Arboviral diseases, West Nile virus disease, Non-neuroinvasive 1 — — 1 9 19 139 344 194 78 38 18 Arboviral diseases, Western equine encephalitis virus disease, Neuroinvasive — — — — — — — — — — — — Arboviral diseases, Western equine encephalitis virus disease, Non-neuroinvasive — — — — — — — — — — — — Babesiosis, Total 18 9 8 28 50 249 686 379 145 117 57 164 Babesiosis, Confirmed 11 8 4 18 39 210 594 329 119 90 39 124 Babesiosis, Probable 7 1 4 10 11 39 92 50 26 27 18 40 Botulism, Total 9 9 19 22 8 37 14 12 17 16 17 21 Botulism, Foodborne — 1 — 2 — 19 1 1 3 2 — 2 Botulism, Infant 9 6 15 18 5 15 10 11 11 12 15 17 Botulism, Other (wound & unspecified) — 2 4 2 3 3 3 — 3 2 2 2 Brucellosis 5 6 12 14 12 10 4 17 11 12 5 19 Campylobacteriosis 3,289 3,104 3,053 4,559 4,615 6,018 7,983 5,907 4,885 5,665 4,097 6,945 Chancroid — 1 — 2 — — 1 — 3 — — — Chlamydia trachomatis infection 118,413 124,918 120,969 154,221 124,652 115,560 147,782 129,334 124,265 155,523 117,487 165,230 Cholera 3 1 1 1 1 — 3 2 1 2 — — Coccidioidomycosis † 832 741 741 973 667 688 995 1,002 1,038 1,646 1,222 1,284 Cryptosporidiosis, Total 486 551 493 702 648 745 1,279 2,541 2,423 1,771 846 968 Cryptosporidiosis, Confirmed 300 302 286 433 386 449 846 1,668 1,619 1,182 546 620 Cryptosporidiosis, Probable 186 249 207 269 262 296 433 873 804 589 300 348 Cyclosporiasis 1 4 1 4 18 50 213 136 53 21 14 22 Dengue virus infections, Dengue § 155 63 62 53 53 64 127 118 87 54 35 32 Dengue virus infections, Dengue-like illness § 5 3 1 4 3 4 9 3 1 1 3 3 Dengue virus infections, Severe dengue § 1 — — 1 2 2 1 1 1 1 — — Diphtheria — — — — — — — — — — — — Ehrlichiosis and Anaplasmosis, Anaplasma phagocytophilum infection 25 14 44 159 348 926 1,013 468 205 300 414 235 Ehrlichiosis and Anaplasmosis, Ehrlichia chaffeensis infection 10 7 10 51 132 240 347 154 137 85 31 173 Ehrlichiosis and Anaplasmosis, Ehrlichia ewingii infection — — — 1 2 5 5 5 1 — — 3 Ehrlichiosis and Anaplasmosis, Undetermined ehrlichiosis/anaplasmosis 1 1 3 12 20 25 60 30 11 18 11 8 Giardiasis 980 1,034 1,032 1,337 1,089 1,097 1,532 1,619 1,607 1,712 1,055 2,216 Gonorrhea 33,173 32,955 31,737 41,079 35,513 34,120 44,683 39,106 38,406 48,002 36,763 52,977 Haemophilus influenzae, invasive disease, All ages, all serotypes 481 383 390 582 360 351 375 266 289 390 360 668 Haemophilus influenzae, invasive disease, Age <5 years, Serotype b 4 — 3 2 — 1 3 3 3 3 2 6 Haemophilus influenzae, invasive disease, Age <5 years, Non-b serotype 10 11 18 14 15 10 12 8 13 17 9 22 Haemophilus influenzae, invasive disease, Age <5 years, Nontypeable 23 25 19 14 10 12 12 10 16 8 13 34 Haemophilus influenzae, invasive disease, Age <5 years, Unknown serotype 17 15 12 14 15 14 11 10 6 19 22 32 Hansen's disease 10 8 4 7 5 5 3 14 6 11 3 2 Hantavirus infection, non-hantavirus pulmonary syndrome — — 1 1 1 — — — — — 1 2 Hantavirus pulmonary syndrome 3 1 1 4 3 1 6 2 1 1 4 4 Hemolytic uremic syndrome post-diarrheal 14 8 14 18 23 29 41 41 22 43 26 28 Hepatitis, A, acute ¶ 110 123 98 141 102 106 261 281 284 204 106 191 Hepatitis, B, acute ¶ 212 244 213 319 259 230 309 254 248 281 225 424 Hepatitis, B, perinatal infection ¶ 1 2 2 5 1 3 3 3 1 2 4 5 Hepatitis, C, acute ¶ 256 248 220 321 247 219 283 211 209 239 165 324 Human immunodeficiency virus diagnoses 3,303 3,307 3,468 3,242 3,469 3,510 3,244 3,460 2,911 2,609 1,847 403 Influenza-associated pediatric mortality 2 9 15 32 10 3 7 — — 2 — 2 Invasive pneumococcal disease, All ages 1,669 1,808 2,014 2,270 1,344 981 886 593 766 1,360 1,320 2,615 Invasive pneumococcal disease, All ages, Confirmed 1,667 1,806 2,013 2,269 1,342 980 886 590 765 1,356 1,319 2,610 Invasive pneumococcal disease, All ages, Probable 2 2 1 1 2 1 — 3 1 4 1 5 Invasive pneumococcal disease, Age <5 years 83 126 127 124 76 88 62 40 63 94 106 153 Invasive pneumococcal disease, Age <5 years, Confirmed 83 126 127 124 74 87 62 40 63 92 106 153 Invasive pneumococcal disease, Age <5 years, Probable — — — — 2 1 — — — 2 — — Legionellosis 275 230 256 298 305 439 633 688 736 876 591 814 Leptospirosis 4 — 6 3 2 3 8 10 9 11 5 17 Listeriosis 32 39 31 53 46 73 89 96 99 81 55 92 Lyme disease, Total 881 837 1,056 1,607 2,017 5,425 9,686 4,860 3,108 2,954 1,942 2,056 Lyme disease, Confirmed 592 568 698 1,056 1,341 4,076 7,393 3,699 2,179 2,047 1,276 1,278 Lyme disease, Probable 289 269 358 551 676 1,349 2,293 1,161 929 907 666 778 Malaria 87 85 75 107 144 197 231 259 226 211 117 216 Measles, Total 2 — 4 7 20 21 7 1 2 2 — 19 Measles, Indigenous — — 2 7 16 20 4 — — 1 — 18 Measles, Imported 2 — 2 — 4 1 3 1 2 1 — 1 Meningococcal disease, All serogroups 29 29 32 50 34 28 33 20 19 27 22 52 Meningococcal disease, Serogroups ACWY 9 8 9 16 14 8 6 9 8 11 10 18 Meningococcal disease, Serogroup B 7 8 4 13 7 4 4 3 6 7 9 14 Meningococcal disease, Other serogroups 2 1 5 2 1 2 1 3 1 1 — 2 Meningococcal disease, Unknown serogroup 11 12 14 19 12 14 22 5 4 8 3 18 Mumps 202 266 314 457 347 200 129 118 405 859 1,097 1,975 Novel Influenza A virus infections — — — 1 1 1 — 18 — — 1 1 Pertussis 1,272 1,232 1,084 1,380 1,279 1,312 1,802 1,224 1,087 1,378 1,820 3,102 Plague — — — — — 1 1 1 1 — — — Poliomyelitis, paralytic — — — — — — — — — — — — Poliovirus infection, nonparalytic — — — — — — — — — — — — Psittacosis — 1 2 — — 2 1 1 3 1 1 — Q fever, Total 3 7 10 15 26 12 27 10 12 16 7 19 Q fever, Acute 3 7 6 13 22 10 25 7 8 13 5 13 Q fever, Chronic — — 4 2 4 2 2 3 4 3 2 6 Rabies, Animal 233 315 414 400 455 504 404 636 485 374 217 167 Rabies, Human — — — — — — — — — — — — Rubella 1 — — — — — — — — — — — Rubella, congenital syndrome — — — — — — — — — — 2 — Salmonellosis 2,415 2,077 2,221 3,786 3,513 4,469 7,317 6,544 6,268 6,495 3,687 5,058 Severe acute respiratory syndrome-associated coronavirus disease — — — — — — — — — — — — Shiga toxin-producing Escherichia coli ** 329 271 395 573 521 770 1,233 948 782 842 571 934 Shigellosis 1,699 1,640 1,663 2,027 1,801 1,825 2,106 1,650 1,466 1,949 1,349 1,922 Smallpox — — — — — — — — — — — — Spotted fever rickettsiosis, Total 30 47 82 224 408 610 864 641 499 388 174 302 Spotted fever rickettsiosis, Confirmed 4 2 9 5 15 19 28 27 14 12 4 15 Spotted fever rickettsiosis, Probable 26 45 73 219 393 591 836 614 485 376 170 287 Streptococcal toxic shock syndrome 27 37 24 47 18 17 16 13 12 14 20 38 Syphilis, Total, all stages †† 6,490 6,907 6,831 8,612 6,861 6,453 8,293 6,856 6,642 8,662 6,648 8,787 Syphilis, Congenital 52 55 45 44 48 51 50 59 52 59 61 52 Syphilis, Primary and secondary 2,027 2,124 2,119 2,710 2,163 2,045 2,660 2,247 2,128 2,726 2,115 2,750 Tetanus 1 1 3 5 1 4 3 5 3 3 1 4 Toxic shock syndrome (other than Streptococcal) 2 5 2 — 2 4 7 2 4 2 6 4 Trichinellosis — — 1 2 1 2 2 3 3 4 — 8 Tuberculosis 478 642 698 777 716 837 691 853 713 803 740 1,324 Tularemia 1 5 5 11 29 34 40 30 19 20 14 22 Typhoid fever 32 22 20 32 28 32 36 48 43 22 24 37 Vancomycin-intermediate Staphylococcus aureus 10 13 9 12 8 7 12 11 8 7 3 8 Vancomycin-resistant Staphylococcus aureus — — — — — — — — — — — — Varicella morbidity 781 738 733 1,026 871 608 579 407 683 827 721 979 Varicella mortality — — — — — — 1 1 1 — — — Vibriosis, Total 48 29 29 50 67 108 227 229 165 137 62 122 Vibriosis, Confirmed 48 25 27 50 66 105 223 225 161 132 61 118 Vibriosis, Probable — 4 2 — 1 3 4 4 4 5 1 4 Viral hemorrhagic fevers, Crimean-Congo hemorrhagic fever virus — — — — — — — — — — — — Viral hemorrhagic fevers, Ebola virus — — — — — — — — — — — — Viral hemorrhagic fevers, Guanarito virus — — — — — — — — — — — — Viral hemorrhagic fevers, Junin virus — — — — — — — — — — — — Viral hemorrhagic fevers, Lassa virus — — — — — — — — — — — — Viral hemorrhagic fevers, Lujo virus — — — — — — — — — — — — Viral hemorrhagic fevers, Machupo virus — — — — — — — — — — — — Viral hemorrhagic fevers, Marburg virus — — — — — — — — — — — — Viral hemorrhagic fevers, Sabia virus — — — — — — — — — — — — Yellow fever — — — — — — — — — — — 1 Zika virus, Zika virus disease, congenital §§ — — 1 — 2 1 6 1 4 7 3 5 Zika virus, Zika virus disease, non-congenital 139 180 137 190 287 574 1,147 1,001 520 378 341 238 Zika virus, Zika virus infection, congenital §§ — — — — 1 — 5 5 4 12 7 11 Zika virus, Zika virus infection, non-congenital 5 25 38 39 47 74 98 81 94 141 106 163 —: No reported cases * Month is defined using MMWR week (http://wwwn.cdc.gov/nndss/document/MMWR_Week_overview.pdf). MMWR week calendars can be found at http://wwwn.cdc.gov/nndss/script/ downloads.aspx. † Reportable in <25 states. § Total number of reported laboratory-positive dengue cases, including all confirmed cases [by anti-dengue virus (DENV) molecular diagnostic methods or seroconversion of anti-DENV IgM] and all probable cases (by a single, positive anti-DENV IgM). ¶ Chronic hepatitis B and C data are not included in NNDSS tables but reported case counts are included in the annual Summary of Viral Hepatitis, published online by CDC's Division of Viral Hepatitis, available at https://www.cdc.gov/hepatitis/statistics/2015surveillance/index.htm. ** Includes Escherichia coli O157:H7; shiga toxin-positive, serogroup non-O157; and shiga toxin positive, not serogrouped. †† Includes syphilis of all stages, including cases where stage of syphilis is not stated. §§ Data reported to ArboNET using the national surveillance case definition for congenital Zika virus disease or infection (CSTE Position Statement 16-ID-01). Additional data reported to the US Zika Pregnancy Registry for outcomes of pregnancies with laboratory evidence of possible Zika virus infection are available at https://www.cdc.gov/zika/reporting/pregnancy-outcomes.html. Cases reported to the US Zika Pregnancy Registry might not meet the national surveillance case definition for congenital Zika virus disease or infection. Notes: These are annual cases of selected infectious national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data reported by the 50 states, New York City, the District of Columbia, and the U.S. territories are collated and published. Cases are reported by state health departments to CDC weekly. Annual data may differ from previously reported weekly and quarterly data due to revision of information and delayed reporting. The list of national notifiable infectious diseases and conditions for 2016 and their national surveillance case definitions are available at https://wwwn.cdc.gov/nndss/conditions/notifiable/2016/infectious-diseases/, https://wwwn.cdc.gov/nndss/conditions/notifiable/2016/infectious-diseases/. This list incorporates the Council of State and Territorial Epidemiologists (CSTE) position statements approved in 2015 by CSTE for national surveillance, that were implemented in January 2016, including updated surveillance case definitions for acute hepatitis C and chronic hepatitis C virus infections. 2016 data are reported through June 30, 2017. Publication criteria for the finalized 2016 data are available at https://wonder.cdc.gov/nndss/documents/2016_NNDSS_Publication_Criteria.pdf, /nndss/documents/2016_NNDSS_Publication_Criteria.pdf. See also https://wwwn.cdc.gov/nndss/document/guide_to_interpreting_provisional_and_finalized_nndss_data_tables.pdf, Guide to Interpreting Provisional and Finalized NNDSS Data. Population estimates for incidence rates are July 1st, 2016 estimates obtained from the National Center for Health Statistics (NCHS) postcensal estimates of the resident population of the United States for July 1, 2011 - July 1, 2016, by year, county, single year of age (range: 0 to 85 years), bridged-race (white, black or African American, American Indian or Alaska Native, Asian, or Pacific Islander), Hispanic ethnicity (not Hispanic or Latino, Hispanic or Latino), and sex (Vintage 2016), prepared under a collaborative arrangement with the U.S. Census Bureau. Population estimates for states as of June 26, 2017 are available at https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm, https://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm. Population estimates for territories are the 2016 mid-year estimates from the U.S. Census Bureau International Data Base accessed on July 24, 2017 at https://www.census.gov/population/international/data/idb/informationGateway.php, https://www.census.gov/population/international/data/idb/informationGateway.php. The choice of population denominators for incidence is based on the availability of population data at the time of publication preparation. NNDSS data displayed in the annual tables are accurate as of October 17, 2017; source data may be updated as additional information is received. Annual tables for 2016 are available on https://wonder.cdc.gov/nndss/nndss_annual_tables_menu.asp, CDC WONDER. Annual summary reports from 1993-2015 are available as published in the https://www.cdc.gov/mmwr/mmwr_nd/index.html, MMWR. Annual summary reports from 1952-1992 are available as published in the MMWR in the https://stacks.cdc.gov/, CDC Stacks. https://wwwn.cdc.gov/nndss/, National Notifiable Diseases Surveillance System Provided by https://wonder.cdc.gov, CDC WONDER